Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system

被引:1
|
作者
Luo, Qian [1 ,2 ,3 ]
Yang, Jiaying [2 ,3 ]
Yang, Mei [2 ,3 ]
Wang, Yingtong [4 ]
Liu, Yiran [1 ]
Liu, Jixuan [2 ,3 ]
Kalvakolanu, Dhan, V [5 ]
Cong, Xianling [1 ]
Zhang, Jinnan [1 ]
Zhang, Ling [2 ,3 ]
Guo, Baofeng [1 ]
Duo, Yanhong [6 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Plast Surg, Changchun 130033, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Key Lab Pathobiol, Minist Educ, Changchun 130021, Peoples R China
[3] Jilin Univ, Coll Basic Med Sci, Dept Biomed Sci, Changchun 130021, Peoples R China
[4] Jilin Univ, Hosp Stomatol, Undergraduate Ctr, Changchun 130021, Peoples R China
[5] Univ Maryland, Greenebaum NCI Comprehens Canc Ctr, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA
[6] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA
基金
中国国家自然科学基金;
关键词
Nanoscale delivery platforms; Nano-sized particles; Disorders of the central nervous system; Cerebrovascular barrier; ENHANCED DRUG-DELIVERY; SILICA NANOPARTICLES; PARKINSONS-DISEASE; IN-VITRO; GOLD NANOPARTICLES; LOADED LIPOSOMES; TUMOR BARRIER; GENE DELIVERY; GLIOBLASTOMA; THERAPY;
D O I
10.1016/j.mtbio.2025.101457
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Central nervous system (CNS) diseases are a major cause of disability and death worldwide. Due to the bloodbrain barrier (BBB), drug delivery for CNS diseases is extremely challenging. Nano-delivery systems can overcome the limitations of BBB to deliver drugs to the CNS, improve the ability of drugs to target the brain and provide potential therapeutic methods for CNS diseases. At the same time, the choice of different drug delivery methods (bypassing BBB or crossing BBB) can further optimize the therapeutic effect of the nano-drug delivery system. This article reviews the different methods of nano-delivery systems to overcome the way BBB enters the brain. Different kinds of nanoparticles to overcome BBB were discussed in depth.
引用
收藏
页数:32
相关论文
共 50 条
  • [41] Matrix metalloproteinases cause blood-brain barrier disruption in central nervous system tuberculosis
    Brilha, Sara
    Ong, Catherine W. M.
    Friedland, Jon S.
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 27 - 27
  • [42] Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System
    Mustafa, Yasmin Mucuna
    Meuren, Lana Monteiro
    Antunes Coelho, Sharton Vinicius
    de Arruda, Luciana Barros
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [43] Targeted Analysis of Central Nervous System Using Blood-Brain Barrier Shuttle Peptides
    Huang Yan-Yan
    Zhao Rui
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2019, 47 (10) : 1629 - 1638
  • [44] The role of peptides in blood-brain barrier nanotechnology
    Teixido, Meritxell
    Giralt, Ernest
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (02) : 163 - 173
  • [45] Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier
    Wang, Xiang
    Yin, Yue
    Zhou, Huaijuan
    Chi, Bowen
    Guan, Ling
    Li, Pei
    Li, Jinhua
    Wang, Yilong
    EXPLORATION, 2024,
  • [46] From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis
    Fullstone, G.
    Nyberg, S.
    Tian, X.
    Battaglia, G.
    INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 130: NANOTECHNOLOGY AND THE BRAIN, 2016, 130 : 41 - 72
  • [47] Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system
    Kim, Jinhwan
    Ahn, Song Ih
    Kim, YongTae
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2019, 73 : 8 - 18
  • [48] Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
    Bertrand, Luc
    Nair, Madhavan
    Toborek, Michal
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (35) : 5477 - 5486
  • [49] Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
    Sharma, Aruna
    Menon, Preeti
    Muresanu, Dafin F.
    Ozkizilcik, Asya
    Tian, Z. Ryan
    Lafuente, Jose V.
    Sharma, Hari S.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (09) : 1092 - 1117
  • [50] MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity
    Ma, Feifei
    Zhang, Xuejing
    Yin, Ke-Jie
    EXPERIMENTAL NEUROLOGY, 2020, 323